Jason Luke Named New Chief Medical Officer at Strand Therapeutics
OncoDaily GU · Lycoming Career and Technology Center, PA · 2 wk ago
HealthcareFull-time
Jason Luke, Chief Medical Officer at Strand Therapeutics, recently shared his career update:
“Extremely excited for this new opportunity and career challenge!
Strand Therapeutics is a leader in RNA engineering, lipid nanoparticle technology, and now clinical cancer immunotherapy.
- Our lead program, STX-001, is rapidly advancing with multiple clinical programs coming.
- Time to work!
Strand Therapeutics proudly announced that Jason Luke will join their team as Chief Medical Officer.
Previously, Jason was a professor at UPMC and brings decades of expertise in cancer immunotherapies to the team.
For more posts featuring Jason Luke, visit OncoDaily.